Well done Chris and the Anteo team, we hope this will generate...

Well done Chris and the Anteo team, we hope this will generate some significant cash flow , Anteo approved products are ready to go and for sale now , something the market has missed .

Anteo’s technology, in particular the newly developed particle conjugation kits (NANO, MICRO and Gold) were enthusiastically received during our visit with end customers. These AnteoBind™ enhanced products were immediately recognised as being innovative ‘ingredients’ that will potentially help Chinese IVD and POC companies improve assay performance across a wide variety of diagnostic applications such as pregnancy testing, cardiac assessment (Troponin), infectious disease detection (HIV and Hepatitis) and cancer diagnosis.

Anteo’s Chief Executive Officer, Christopher Parker, said: “GeneoDX have moved very rapidly to advance this distribution agreement, and the quality of the introductions to IVD and POC companies in China can only be described as first rate. Many are now actively assessing our new Anteo products and how these could be integrated with existing product manufacturing processes. “Training, marketing activities and commercial negotiations are ongoing. With the CACLP exhibition next month, and through GeneoDX’s own activities, we are confident the pipeline of commercial agreements in China will grow rapidly. We look forward to updating shareholders on these developments and delivering tangible sales outcomes”.